Stockreport

Bayer gains full Vitrakvi rights from Eli Lilly's Loxo [Reuters]

LOXO ONCOLOGY  (LOXO) 
Last loxo oncology earnings: 11/8 06:45 am Check Earnings Report
US:NASDAQ Investor Relations: ir.loxooncology.com
PDF Bayer gains full Vitrakvi rights from Eli Lilly's Loxo | Reuters 3 Min Read FRANKFURT (Reuters) - German drugmaker Bayer took full control of Vitrakvi, a drug used again [Read more]